IE
FLACU

Israel Englander’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Israel Englander’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-225,001
Closed -$2.26M – 7480
2021
Q2 		$2.26M Hold
225,001
– – ﹤0.01% 3817
2021
Q1 		$2.29M Sell
225,001
-276,333
-55% -$2.95M ﹤0.01% 3412
2020
Q4 		$5.2M Buy
+501,334
New +$5.23M ﹤0.01% 2394

Other funds holding FLACU

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Israel Englander's FLACU Position: Q3 2021 in Review

Israel Englander sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q3 2021, closing a stake of 225,001 shares — an estimated $2.26M sold.

Israel Englander first reported a position in FLACU in Q4 2020 and held it in 3 quarters. The position peaked at $5.2M in Q4 2020. 26 funds tracked by Wall St. Rank hold FLACU as of Q3 2021.

  • Israel Englander reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Israel Englander sold 225,001 Frazier Lifesciences Acquisition Corporation Unit shares in Q3 2021, an estimated $2.26M.
  • Israel Englander first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 3 quarters.
  • Israel Englander's Frazier Lifesciences Acquisition Corporation Unit position peaked at $5.2M in Q4 2020.
  • 26 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q3 2021.

Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.